• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病严重程度对心理和功能结局的影响:一项横断面分析。

The Impact of Chronic Obstructive Pulmonary Disease Severity on Psychological and Functional Outcomes: A Cross-Sectional Analysis.

作者信息

Crisan Alexandru Florian, Pescaru Camelia Corina, Maritescu Adelina, Stoicescu Emil Robert, Carunta Vlad, Oancea Cristian

机构信息

Research Center for Assessment of Human Motion, Functionality, and Disability, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Pulmonary Rehabilitation Center, Clinical Hospital of Infectious Diseases and Pulmonology, "Victor Babes", Gheorghe Adam Street 13, 300310 Timisoara, Romania.

出版信息

J Clin Med. 2025 Mar 10;14(6):1865. doi: 10.3390/jcm14061865.

DOI:10.3390/jcm14061865
PMID:40142673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11942961/
Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by significant physical and psychological burdens. However, the influence of the disease's severity on psychological factors and functional outcomes remains unclear. This study aimed to investigate the impact of disease severity on psychological factors and functional outcomes in patients with moderate and severe COPD. This cross-sectional study included 98 patients with moderate ( = 44) or severe ( = 54) COPD. Anxiety and depression, guilt and shame, self-compassion, self-efficacy (PRAISE), and fear of negative evaluation were assessed. Functional capacity was evaluated with the six minute walk test (6MWT), and disease impact was assessed via the COPD assessment test (CAT). Lung function was measured through post-bronchodilator spirometry. : Compared with those with moderate COPD, those with severe COPD presented significantly greater levels of guilt (12 vs. 10; < 0.01), anxiety (10 vs. 6.5; < 0.01), and depression (7.5 vs. 6; = 0.06). Self-compassion was significantly lower in the severe group (3.16 vs. 3.41; < 0.01), whereas shame and fear of negative evaluation scores were similar between the groups. The functional capacity was significantly reduced in patients with severe COPD (217.04 ± 70.16 m vs. 286.46 ± 77.92 m; < 0.01). Disease impact and dyspnea (CAT, mMRC) were worse in severe cases ( < 0.01). Patients with severe COPD presented significantly greater levels of guilt, anxiety, and depression, alongside lower self-compassion, worse functional outcomes, and poorer health-related quality of life, compared to those with moderate COPD.

摘要

慢性阻塞性肺疾病(COPD)是一种进行性肺部疾病,具有显著的身心负担。然而,该疾病严重程度对心理因素和功能结局的影响仍不清楚。本研究旨在调查疾病严重程度对中度和重度COPD患者心理因素和功能结局的影响。这项横断面研究纳入了98例中度(n = 44)或重度(n = 54)COPD患者。评估了焦虑和抑郁、内疚和羞耻、自我同情、自我效能感(PRAISE)以及对负面评价的恐惧。通过六分钟步行试验(6MWT)评估功能能力,并通过慢性阻塞性肺疾病评估测试(CAT)评估疾病影响。通过支气管扩张剂后肺量计测量肺功能。结果显示:与中度COPD患者相比,重度COPD患者的内疚感(12 vs. 10;P < 0.01)、焦虑(10 vs. 6.5;P < 0.01)和抑郁(7.5 vs. 6;P = 0.06)水平显著更高。重度组的自我同情显著更低(3.16 vs. 3.41;P < 0.01),而两组之间的羞耻感和对负面评价的恐惧得分相似。重度COPD患者的功能能力显著降低(217.04 ± 70.16米 vs. 286.46 ± 77.92米;P < 0.01)。严重病例的疾病影响和呼吸困难(CAT,mMRC)更严重(P < 0.01)。与中度COPD患者相比,重度COPD患者的内疚、焦虑和抑郁水平显著更高,同时自我同情更低,功能结局更差,与健康相关的生活质量更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/97d67f97cf9a/jcm-14-01865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/e6c7a25a66ef/jcm-14-01865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/1dd96a78e91c/jcm-14-01865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/97d67f97cf9a/jcm-14-01865-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/e6c7a25a66ef/jcm-14-01865-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/1dd96a78e91c/jcm-14-01865-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb7/11942961/97d67f97cf9a/jcm-14-01865-g003.jpg

相似文献

1
The Impact of Chronic Obstructive Pulmonary Disease Severity on Psychological and Functional Outcomes: A Cross-Sectional Analysis.慢性阻塞性肺疾病严重程度对心理和功能结局的影响:一项横断面分析。
J Clin Med. 2025 Mar 10;14(6):1865. doi: 10.3390/jcm14061865.
2
Exploration of the feasibility to combine patients with chronic obstructive pulmonary disease and chronic heart failure in self-management groups with focus on exercise self-efficacy.探讨将慢性阻塞性肺疾病和慢性心力衰竭患者合并到以运动自我效能为重点的自我管理小组中的可行性。
Scand J Prim Health Care. 2022 Jun;40(2):208-216. doi: 10.1080/02813432.2022.2073961. Epub 2022 May 16.
3
The relationship between steps of 6MWT and COPD severity: a cross-sectional study.6分钟步行试验步数与慢性阻塞性肺疾病严重程度的关系:一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2018 Dec 28;14:141-148. doi: 10.2147/COPD.S188994. eCollection 2019.
4
Effect of home noninvasive positive pressure ventilation combined with pulmonary rehabilitation on dyspnea severity and quality of life in patients with severe stable chronic obstructive pulmonary disease combined with chronic type II respiratory failure: a randomized controlled trial.家庭无创正压通气联合肺康复对重度稳定期慢性阻塞性肺疾病合并慢性Ⅱ型呼吸衰竭患者呼吸困难严重程度及生活质量的影响:一项随机对照试验
BMC Pulm Med. 2025 Apr 21;25(1):185. doi: 10.1186/s12890-025-03656-3.
5
Dual-task performance and balance in patients with severe COPD: a cross-sectional study.重度慢性阻塞性肺疾病患者的双重任务表现与平衡:一项横断面研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241287302. doi: 10.1177/17534666241287302.
6
Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).使用慢性阻塞性肺疾病评估测试(CAT)对慢性阻塞性肺疾病患者健康相关生活质量(HRQOL)的预测因素
West Afr J Med. 2020 Jul-Aug;37(3):275-280.
7
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.针对患有慢性阻塞性肺疾病和至少一种其他长期疾病的成年人的定制或改编干预措施:一项混合方法综述。
Cochrane Database Syst Rev. 2021 Jul 26;7(7):CD013384. doi: 10.1002/14651858.CD013384.pub2.
8
Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary disease in China.中国慢性阻塞性肺疾病患者阻塞性睡眠呼吸暂停的预测因素和结局。
BMC Pulm Med. 2022 Jan 4;22(1):16. doi: 10.1186/s12890-021-01780-4.
9
Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.慢性阻塞性肺疾病患者胸痛的患病率及其与患者特征的关系:一项横断面观察性研究。
BMC Pulm Med. 2016 Apr 6;16:47. doi: 10.1186/s12890-016-0210-8.
10
Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.用于治疗慢性阻塞性肺疾病中抑郁症的心理疗法。
Cochrane Database Syst Rev. 2019 Mar 6;3(3):CD012347. doi: 10.1002/14651858.CD012347.pub2.

本文引用的文献

1
GOLD COPD report: 2024 update.慢性阻塞性肺疾病全球倡议(GOLD)报告:2024年更新版
Lancet Respir Med. 2024 Jan;12(1):15-16. doi: 10.1016/S2213-2600(23)00461-7. Epub 2023 Dec 4.
2
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.2020-50 年全球 204 个国家和地区慢性阻塞性肺疾病的全球经济负担:一项健康增强型宏观经济建模研究。
Lancet Glob Health. 2023 Aug;11(8):e1183-e1193. doi: 10.1016/S2214-109X(23)00217-6.
3
The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease.
焦虑和抑郁对慢性阻塞性肺疾病的影响。
Adv Respir Med. 2023 Mar 10;91(2):123-134. doi: 10.3390/arm91020011.
4
Nonpharmacological management of psychological distress in people with COPD.慢性阻塞性肺疾病患者心理困扰的非药物管理。
Eur Respir Rev. 2023 Mar 22;32(167). doi: 10.1183/16000617.0170-2022. Print 2023 Mar 31.
5
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.慢性阻塞性肺疾病全球倡议组织2023年报告:《慢性阻塞性肺疾病全球倡议》执行摘要
Am J Respir Crit Care Med. 2023 Apr 1;207(7):819-837. doi: 10.1164/rccm.202301-0106PP.
6
Self-Efficacy Intervention Programs in Patients with Chronic Obstructive Pulmonary Disease: Narrative Review.慢性阻塞性肺疾病患者的自我效能干预方案:叙事性综述。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 18;16:3397-3403. doi: 10.2147/COPD.S338720. eCollection 2021.
7
Modified Medical Research Council and COPD Assessment Test Cutoff Points.改良版医学研究委员会问卷和慢性阻塞性肺疾病评估测试截断点。
Respir Care. 2021 Dec;66(12):1876-1884. doi: 10.4187/respcare.08889. Epub 2021 Oct 20.
8
Stigma Experiences in People with Chronic Obstructive Pulmonary Disease: An Integrative Review.慢性阻塞性肺疾病患者的污名体验:综合评价。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 4;16:1647-1659. doi: 10.2147/COPD.S306874. eCollection 2021.
9
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
10
Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions.慢性阻塞性肺疾病相关呼吸困难:生理和心理后果、未满足的需求和未来方向。
Int J Chron Obstruct Pulmon Dis. 2019 May 24;14:1127-1138. doi: 10.2147/COPD.S188141. eCollection 2019.